Hippocampus subfield volume reductions in treatment-resistant schizophrenia

Affiliations

¹ Centre de recherche de l'Institut Universitaire en Santé Mentale de Montréal; Montreal, Quebec, Canada; Department of psychiatry and addiction, Faculty of medicine, University of Montreal; Montreal, Quebec, Canada.
² Institut National de Psychiatrie Légale Philippe-Pinel, Montreal, Canada.
³ Centre de recherche de l'Institut Universitaire en Santé Mentale de Montréal; Montreal, Quebec, Canada; Department of psychiatry and addiction, Faculty of medicine, University of Montreal; Montreal, Quebec, Canada; Institut National de Psychiatrie Légale Philippe-Pinel, Montreal, Canada.
⁴ Centre de recherche de l'Institut Universitaire en Santé Mentale de Montréal; Montreal, Quebec, Canada; Department of psychiatry and addiction, Faculty of medicine, University of Montreal; Montreal, Quebec, Canada. Electronic address: stephane.potvin@umontreal.ca.

Alexandra Fortier et al. Schizophr Res. 2025 Jun.

. 2025 Jun:280:10-14.

doi: 10.1016/j.schres.2025.04.006. Epub 2025 Apr 13.

¹ Centre de recherche de l'Institut Universitaire en Santé Mentale de Montréal; Montreal, Quebec, Canada; Department of psychiatry and addiction, Faculty of medicine, University of Montreal; Montreal, Quebec, Canada.
² Institut National de Psychiatrie Légale Philippe-Pinel, Montreal, Canada.
³ Centre de recherche de l'Institut Universitaire en Santé Mentale de Montréal; Montreal, Quebec, Canada; Department of psychiatry and addiction, Faculty of medicine, University of Montreal; Montreal, Quebec, Canada; Institut National de Psychiatrie Légale Philippe-Pinel, Montreal, Canada.
⁴ Centre de recherche de l'Institut Universitaire en Santé Mentale de Montréal; Montreal, Quebec, Canada; Department of psychiatry and addiction, Faculty of medicine, University of Montreal; Montreal, Quebec, Canada. Electronic address: stephane.potvin@umontreal.ca.

No abstract available

Keywords: Hippocampal subfields; MRI; Neuroimaging; Psychosis; Schizophrenia.

Conflict of interest statement

Declaration of competing interest SP and AD received funding from HLS Therapeutics for the current study.